Merit Financial Group, LLC Astrazeneca PLC Transaction History
Merit Financial Group, LLC
- $10.9 Billion
- Q4 2025
A detailed history of Merit Financial Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Merit Financial Group, LLC holds 35,186 shares of AZN stock, worth $3.15 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
35,186
Previous 36,494
3.58%
Holding current value
$3.15 Million
Previous $2.8 Million
12.36%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,548Shares Held
503MCall Options Held
5.54MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...